Drug addiction and associated HIV risk behavior are significant public health problems, and most addiction treatments fail to produce lasting behavior change. Prospective memory (ability to implement an intention in the future;e.g., remember to take medication, attend a scheduled meeting) may play a critical role in behavior change such as in addiction treatment (i.e., in order to behave differently, one has to remember to behavior differently). Despite an intuitive role for prospective memory in addiction and findings of impaired prospective memory in drug abusers, no study has targeted prospective memory for treatment. Prospective memory also provides a mechanistic account of exciting but theoretically challenging findings that working memory training decreased delay discounting (people showed greater self-control by choosing larger later rewards over smaller sooner rewards in a lab task) in addicted individuals, and reduced drinking in alcoholics. Prospective memory (which relies on working memory) is the missing link because a larger working memory capacity is more likely to have space to hold long term goals in mind (prospective memory) while faced with other demands including temptations at conflict with those longer term goals. Improved prospective memory results in a person more successfully obtaining longer term rewards, which over time reinforces greater valuation of delayed rewards. Working memory training only addresses 1 of multiple components of prospective memory. Thus, this highly innovative proposal will develop the 1st prospective memory training to encompass the multiple components of prospective memory (working memory, retrospective memory, executive functions), in order to increase self- control (ability to wait for delayed rewards), and therefore reduce drug use and associated HIV risk behavior. The computerized prospective memory training will use immersive technology to simulate everyday life prospective memory challenges. 3 studies in methadone patients who use cocaine will move from basic research to refinement of clinical intervention. Exp. 1 will inform intervention development by determining the optimal # of prospective memory tasks (intentions to remember) for subsequent experiments (Aim 1a). Exp. 2 is a 'proof of concept'test of the hypothesis that prospective memory training improves prospective memory (Aim 2a), and will provide 'dose-response'information to determine the optimal # of training sessions (Aim 2b). Exp. 3 is a randomized controlled trial (3 groups: prospective memory training, working memory training, control) to test the preliminary efficacy of the prospective memory training to improve the target behaviors. We hypothesize that prospective memory training will decrease delay discounting (Aim 3a;primary), drug use, and HIV risk behavior (Aim 3b;secondary), relative to control. A secondary hypothesis is that prospective memory training will produce greater decreases in delay discounting than working memory training. In addition to drug dependence and HIV, data from this project have broad implications for prevention and treatment of the many clinical disorders in which behavior change is critical (obesity, cardiovascular disease, cancer, diabetes).
Drug addiction and associated HIV risk behavior are significant public health problems requiring major behavior change;however, most treatments for addiction fail to produce lasting behavior change. This grant will develop a novel memory training intervention that will improve self-control in drug addicted individuals, with the goal of decreasing drug use and HIV risk behavior. If successful, the intervention will also have broad implications for other disorders requiring behavior change (e.g., obesity).
|Barrett, Frederick S; Carbonaro, Theresa M; Hurwitz, Ethan et al. (2018) Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition. Psychopharmacology (Berl) 235:2915-2927|
|Berry, Meredith S; Johnson, Matthew W (2018) Does being drunk or high cause HIV sexual risk behavior? A systematic review of drug administration studies. Pharmacol Biochem Behav 164:125-138|
|Sweeney, Mary M; Rass, Olga; DiClemente, Cara et al. (2018) Working Memory Training for Adolescents With Cannabis Use Disorders: A Randomized Controlled Trial. J Child Adolesc Subst Abuse 27:211-226|
|Johnson, Matthew W; Herrmann, Evan S; Sweeney, Mary M et al. (2017) Cocaine administration dose-dependently increases sexual desire and decreases condom use likelihood: The role of delay and probability discounting in connecting cocaine with HIV. Psychopharmacology (Berl) 234:599-612|
|Horan, William P; Johnson, Matthew W; Green, Michael F (2017) Altered experiential, but not hypothetical, delay discounting in schizophrenia. J Abnorm Psychol 126:301-311|
|Tompkins, D Andrew; Johnson, Patrick S; Smith, Michael T et al. (2016) Temporal preference in individuals reporting chronic pain: discounting of delayed pain-related and monetary outcomes. Pain 157:1724-32|
|Sheffer, Christine E; Mackillop, James; Fernandez, Arislenia et al. (2016) Initial examination of priming tasks to decrease delay discounting. Behav Processes 128:144-52|
|Dunn, Kelly E; Barrett, Frederick S; Herrmann, Evan S et al. (2016) Behavioral risk assessment for infectious diseases (BRAID): Self-report instrument to assess injection and noninjection risk behaviors in substance users. Drug Alcohol Depend 168:69-75|
|Sweeney, Mary M; Rass, Olga; Johnson, Patrick S et al. (2016) Initial feasibility and validity of a prospective memory training program in a substance use treatment population. Exp Clin Psychopharmacol 24:390-399|
|Rass, Olga; Schacht, Rebecca L; Buckheit, Katherine et al. (2015) A randomized controlled trial of the effects of working memory training in methadone maintenance patients. Drug Alcohol Depend 156:38-46|
Showing the most recent 10 out of 11 publications